Down syndrome fibroblasts and mouse Prep1-overexpressing cells display increased sensitivity to genotoxic stress

Nucleic Acids Research

Volumn 38, Issue 11, 2010, Pages 3595-3604

  Micali, Nicola ^a,d   Longobardi, Elena ^b   Iotti, Giorgio ^b   Ferrai, Carmelo ^a,e   Castagnaro, Laura ^a   Ricciardi, Mario ^a,f   Blasi, Francesco ^a,b,c   Crippa, Massimo P ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d IFOM (Fondazione Istituto FIRC di Oncologia Molecolare)   (Italy)

^e IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^f UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; LUCIFERASE; PROTEIN BCL XL; PROTEIN P53; PROTEIN PREP1; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL STRAIN COS7; CELL STRESS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN SYNDROME; EMBRYONAL CARCINOMA STEM CELL; ENZYME ASSAY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY ANALYSIS;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELLS, CULTURED; DOWN SYNDROME; EMBRYONAL CARCINOMA STEM CELLS; ETOPOSIDE; FIBROBLASTS; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HUMANS; MICE; PHENOTYPE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 77951586942     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq019     Document Type: Article

References (25)

1. Mukherjee,K. and Bürglin,T.R. (2007) Comprehensive analysis of animal TALE homeobox genes: new conserved motifs and cases of accelerated evolution. J. Mol. Evol., 65, 137-153.
2. Ferretti,E., Villaescusa,J.C., Di Rosa,P., Fernandez-Diaz,L.C., Longobardi,E., Mazzieri,R., Miccio,A., Micali,N., Selleri,L., Ferrari,G. et al. (2006) Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol. Cell. Biol., 26, 5650-5662.
3. Penkov,D., Di Rosa,P., Fernandez Diaz,L., Basso,V., Ferretti,E., Grassi,F., Mondino,A. and Blasi,F. (2005) Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursors. Mol. Cell. Biol., 25, 10768-10781.
4. Oriente,F., Fernandez Diaz,L.C., Miele,C., Iovino,S., Mori,S., Diaz,V.M., Troncone,G., Cassese,A., Formisano,P., Blasi,F. et al. (2008) Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. Mol. Cell. Biol., 28, 5634-5645.
5. Micali,N., Ferrai,C., Fernandez-Diaz,L.C., Blasi,F. and Crippa,M.P. (2009) Prep1 directly regulates the intrinsic apoptotic pathway by controlling Bcl-XL levels. Mol. Cell. Biol., 29, 1143-1151.
6. Desagher,S. and Martinou,J.C. (2000) Mitochondria as the central control point of apoptosis. Trends Cell. Biol., 10, 369-377.
7. Borner,C. (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol., 39, 615-647.
8. Antonarakis,S.E. and Epstein,C.J. (2006) The challenge of Down syndrome. Trends Mol. Med., 12, 473-479.
9. Helguera,P., Pelsman,A., Pigino,G., Wolvetang,E., Head,E. and Busciglio,J. (2005) ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons. J. Neurosci., 25, 2295-2303.
10. Zana,M., Szecsenyi,A., Czibula,A., Bjelik,A., Juhasz,A., Rimanoczy,A., Szabo,K., Vetro,A., Szucs,P., Varkonyi,A. et al. (2006) Age-dependent oxidative stress-induced DNA damage in Down's lymphocytes. Biochem. Biophys. Res. Commun., 345, 726-733.
11. Roat,E., Prada,N., Ferraresi,R., Giovenzana,C., Nasi,M., Troiano,L., Pinti,M., Nemes,E., Lugli,E., Biagioni,O. et al. (2007) Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett., 581, 521-525.
12. Seidl,R., Fang-Kircher,S., Bidmon,B., Cairns,N. and Lubec,G. (1999) Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome. Neurosci. Lett., 260, 9-12.
13. Sawa,A., Oyama,F., Cairns,N.J., Amano,N. and Matsushita,M. (1997) Aberrant expression of bcl-2 gene family in Down's syndrome brains. Brain Res. Mol. Brain Res., 48, 53-59.
14. Berthelsen,J., Viggiano,L., Schulz,H., Ferretti,E., Consalez,G.G., Rocchi,M. and Blasi,F. (1998) PKNOX1, a gene encoding PREP1, a new regulator of Pbx activity, maps on human chromosome 21q22.3 and murine chromosome 17B/C. Genomics, 47, 323-324.
15. Sanchez-Font,M.F., Bosch-Comas,A., Gonzalez-Duarte,R. and Marfany,G. (2003) Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance. Nucleic Acids Res., 31, 2769-2777.
16. Longobardi,E. and Blasi,F. (2003) Overexpression of PREP-1 in F9 teratocarcinoma cells leads to a functionally relevant increase of PBX-2 by preventing its degradation. J. Biol. Chem., 278, 39235-39241.
17. Reisman,D., Eaton,E., McMillin,D., Doudican,N.A. and Boggs,K. (2001) Cloning and characterization of murine p53 upstream sequences reveals additional positive transcriptional regulatory elements. Gene, 274, 129-137.
18. Berthelsen,J., Zappavigna,V., Mavilio,F. and Blasi,F. (1998) Prep1, a novel functional partner of Pbx proteins. EMBO J., 17, 1423-1433.
19. Ferrai,C., Munari,D., Luraghi,P., Pecciarini,L., Cangi,M.G., Doglioni,C., Blasi,F. and Crippa,M.P. (2007) A transcription-dependent micrococcal nuclease-resistant fragment of the urokinase-type plasminogen activator promoter interacts with the enhancer. J. Biol. Chem., 282, 12537-12546.
20. Resnati,M., Pallavicini,I., Daverio,R., Sidenius,N., Bonini,P. and Blasi,F. (2006) Specific immunofluorimetric assay detecting the chemotactic epitope of the urokinase receptor (uPAR). J. Immunol. Methods, 308, 192-202.
21. Fridman,J.S. and Lowe,S.W. (2003) Control of apoptosis by p53. Oncogene, 22, 9030-9040.
22. Lakin,N.D. and Jackson,S.P. (1999) Regulation of p53 in response to DNA damage. Oncogene, 18, 7644-7655.
23. Berger,M.F., Badis,G., Gehrke,A.R., Talukder,S., Philippakis,A.A., Pena-Castillo,L., Alleyne,T.M., Mnaimneh,S., Botvinnik,O.B., Chan,E.T. et al. (2008) Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences. Cell, 133, 1266-1276.
24. Sugars,K.L., Budhram-Mahadeo,V., Packham,G. and Latchman,D.S. (2001) A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acids Res., 29, 4530-4540.
25. Miyashita,T., Harigai,M., Hanada,M. and Reed,J.C. (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res., 54, 3131-3135.